SPORADIC:Activating mutations or amplifications of MET proto-oncogene in >80% of sporadic cases.Gains in chromosomes 3, 7, and 17.FAMILIAL:Hereditary papillary renal carcinoma (HPRC). The gene discussed is MET; the disease is hereditary papillary renal cell carcinoma.